Susan G. Komen has awarded three grants in support of metastatic breast cancer research as part of a collaboration between Komen, UNC Lineberger and Duke Cancer Institute, called the Susan G. Komen Metastatic Breast Cancer Collaborative Research Initiative.
New research by Chad Pecot, MD, and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer.
Dale Ramsden, PhD, Gaorav Gupta, MD, PhD, and team will study an enzyme that is part of an important pathway that repairs damage to genomes.
UNC Lineberger’s Aziz Sancar, MD, PhD, has been named the 2019 recipient of the Hyman L. Battle Distinguished Cancer Research Award.
Cancer genetic testing revealed that Beth Silverstein was at high risk for breast and ovarian cancer. She took charge of her destiny and took preventive steps through surgery, and now celebrates five years as a “previvor” with a fundraiser for UNC Lineberger.
Yuliya Pylayeva-Gupta, PhD, and Gaorav Gupta, MD, PhD, use their natural curiosity and drive to tackle cancer through their research at UNC Lineberger.
UNC Lineberger’s Joel Parker, PhD, associate professor in the UNC School of Medicine Department of Genetics and director of cancer genetics for the UNC Lineberger Bioinformatics Core, presented the Haddow Lecture for The Institute of Cancer Research in London this year. In the lecture, he discussed novel computational methods to explore RNA sequencing data for … Continued
Before he set out to understand how tens of thousands of genes are behaving in breast cancer, Charles M. Perou, PhD, spent five years hunting one gene. That experience started his journey to becoming a world-renowned expert in genomics.
